JP4786538B2 - 親油性薬物送達ビヒクルおよびその使用方法 - Google Patents

親油性薬物送達ビヒクルおよびその使用方法 Download PDF

Info

Publication number
JP4786538B2
JP4786538B2 JP2006533840A JP2006533840A JP4786538B2 JP 4786538 B2 JP4786538 B2 JP 4786538B2 JP 2006533840 A JP2006533840 A JP 2006533840A JP 2006533840 A JP2006533840 A JP 2006533840A JP 4786538 B2 JP4786538 B2 JP 4786538B2
Authority
JP
Japan
Prior art keywords
particles
lipid
composition
amb
apolipoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006533840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526907A (ja
Inventor
ロバート オー． リヤン，
マイケル エヌ． オダ，
Original Assignee
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/004295 external-priority patent/WO2004073684A2/fr
Application filed by チルドレンズ ホスピタル アンド リサーチ センター アット オークランド filed Critical チルドレンズ ホスピタル アンド リサーチ センター アット オークランド
Publication of JP2007526907A publication Critical patent/JP2007526907A/ja
Application granted granted Critical
Publication of JP4786538B2 publication Critical patent/JP4786538B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2006533840A 2003-10-01 2004-08-06 親油性薬物送達ビヒクルおよびその使用方法 Expired - Fee Related JP4786538B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US50803503P 2003-10-01 2003-10-01
US60/508,035 2003-10-01
PCT/US2004/004295 WO2004073684A2 (fr) 2003-02-14 2004-02-13 Vehicule d'administration de medicament lipophile et methodes d'utilisation correspondantes
USPCT/US04/004295 2004-02-13
USPCT/US2004/004295 2004-02-13
PCT/US2004/025412 WO2005039534A1 (fr) 2003-10-01 2004-08-06 Vehicule d'administration de medicament lipophile et methodes d'utilisation de ce vehicule

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010173171A Division JP2010248255A (ja) 2003-10-01 2010-07-30 親油性薬物送達ビヒクルおよびその使用方法

Publications (2)

Publication Number Publication Date
JP2007526907A JP2007526907A (ja) 2007-09-20
JP4786538B2 true JP4786538B2 (ja) 2011-10-05

Family

ID=34910664

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006533840A Expired - Fee Related JP4786538B2 (ja) 2003-10-01 2004-08-06 親油性薬物送達ビヒクルおよびその使用方法
JP2010173171A Withdrawn JP2010248255A (ja) 2003-10-01 2010-07-30 親油性薬物送達ビヒクルおよびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010173171A Withdrawn JP2010248255A (ja) 2003-10-01 2010-07-30 親油性薬物送達ビヒクルおよびその使用方法

Country Status (5)

Country Link
EP (1) EP1677763A1 (fr)
JP (2) JP4786538B2 (fr)
AU (1) AU2004283078A1 (fr)
CA (1) CA2541117A1 (fr)
WO (1) WO2005039534A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4777873B2 (ja) 2003-02-14 2011-09-21 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 親油性薬物送達ビヒクルおよびこれらの使用方法
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
EP1919938B1 (fr) * 2005-08-29 2012-06-06 AMSilk GmbH Protéines de soie arachnéenne modifiées
US8268796B2 (en) 2008-06-27 2012-09-18 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use thereof
EP2313085A2 (fr) * 2008-07-15 2011-04-27 Novartis AG Compositions de peptides amphipatiques immunogènes
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
JP6170047B2 (ja) * 2011-08-31 2017-07-26 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド アポトーシス−ターゲティングナノ粒子
EP2745834B1 (fr) 2012-12-18 2016-09-28 Jens Frauenfeld Particules de Salipro
HUE052677T2 (hu) 2013-09-13 2021-05-28 Salipro Biotech AB Antigén és eljárás annak elõállítására
WO2015138992A1 (fr) 2014-03-14 2015-09-17 University Of Georgia Research Foundation, Inc. Administration de 3-bromopyruvate dans les mitochondries
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
AU2017205337B2 (en) * 2016-01-07 2022-09-08 Tesorx Pharma, Llc Formulations for treating bladder cancer
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609399A1 (fr) * 1987-01-13 1988-07-15 Ire Celltarg Sa Procede d'incorporation d'un ou plusieurs principes actifs lipophiles dans des lipoproteines, lipoproteines obtenues et composition pharmaceutique les contenant
US5840707A (en) * 1993-10-04 1998-11-24 Albany Medical College Stabilizing and delivery means of biological molecules
DE19640092A1 (de) * 1996-09-28 1998-04-16 Beiersdorf Ag Strukturen mit Lipid-Doppelmembranen, in deren lipophilen Bereich längerkettige Moleküle eintauchen oder durch hydrophobe Wechselwirkungen an solche Moleküle angedockt sind
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
KR101111477B1 (ko) * 2002-12-03 2012-02-23 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 치료제와 연결된 콜레스테롤을 포함하는 접합체
JP4777873B2 (ja) * 2003-02-14 2011-09-21 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 親油性薬物送達ビヒクルおよびこれらの使用方法

Also Published As

Publication number Publication date
WO2005039534A8 (fr) 2005-09-09
AU2004283078A1 (en) 2005-05-06
JP2010248255A (ja) 2010-11-04
EP1677763A1 (fr) 2006-07-12
JP2007526907A (ja) 2007-09-20
WO2005039534A1 (fr) 2005-05-06
CA2541117A1 (fr) 2005-05-06

Similar Documents

Publication Publication Date Title
JP4777873B2 (ja) 親油性薬物送達ビヒクルおよびこれらの使用方法
JP2010248255A6 (ja) 親油性薬物送達ビヒクルおよびその使用方法
JP2010248255A (ja) 親油性薬物送達ビヒクルおよびその使用方法
US11998587B2 (en) Lipoprotein complexes and manufacturing and uses thereof
JP2006517972A5 (fr)
AU2015271986B2 (en) Lipoprotein complexes and manufacturing and uses thereof
NZ613524B2 (en) Lipoprotein complexes and manufacturing and uses thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100430

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100730

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100729

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100826

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101125

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110629

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110713

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140722

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees